Home Page / Exhibitors / LOHAS Technology (Beijing) Corporation Limited

LOHAS Technology (Beijing) Corporation Limited

New New products
Beijing City, Beijing 100083
Booth(s):  10418

About

LOHAS Technology (Beijing) Corporation Limited is a high-tech company which provides new medical devices and data analysis platform to primary medical institution, focusing on innovative medical sensor with its application and AI technology. With the unique self-developed algorithm and BioRF™ artery radar technology, we have developed new medical devices which can detect vascular’s stiffness condition, BP, and other cardiovascular diseases.

New Product/Service

Non-invasive Vascular Screening Device

Press Releases

LOHAS Technology (Beijing) Corporation Limited is a high-tech company which provides new medical devices and data analysis platform to primary medical institution, focusing on innovative medical sensor with its application and AI technology.

With the unique self-developed algorithm and technology, BioRF™ artery radar which can accurately collect and analyse pulse wave signal. Using this technology, we have developed new medical devices which can detect vascular’s stiffness condition, BP, and other cardiovascular diseases.

Now, we have developed a non-invasive vascular screening device which is designed for primary care, or one step ahead, home use. Consumers, healthcare providers have both been looking for devices that could quantify people’s health with reliable medical evidence. Different from arm bands, watches, the device we introduce measures brachial-ankle pulse wave velocity (baPWV), an important indicator of vascular health and future cardiovascular risk.

The device is a miniature version of vascular health profiler used in hospital. With Lohas Tech’s patented BioRF™ artery radar inside, the device is xxxx in size. We offer a solution for healthcare providers to screen and monitor cardiovascular risks in community level. The data collected will help doctors or individuals to make informed decision on health intervention, so in the long run a decrease of medical cost is expected.

Brachial-ankle pulse wave velocity (baPWV) as the device outputs is an important cardiovascular health indicator widely used by the medical community, and related medical device has long been available on the market. The device is the first of its kind

to expand the use of baPWV down to a community level, and even family use in the following generation of products.

In the future, we want to build a hospital to home solution targeting vascular health, with all device connected to the cloud. In the system doctors can continuously monitor a patient’s arterial stiffness level and decide the level of intervention a patient needs.

We have researched and developed this technology for 3 years. In January 2015, Lohas Tech succeed in the sixth phase of Microsoft Venture Accelerator among 700 programs. At the same term, we became the top ten of the Innovation e-Therapy Contest in 2015, which was held by Pfizer and startup state magazine. Later the company joined into Talent’s Group Camp, the first Chinese Internet Whampoa Military Academy which was held by Kai-fu Lee and Xiao-ping Xu, and stepped into Taiku Incubator and ARM Antitron Space Accelerator. In Jun. 2017, our product appeared in 2017 CES Asia.

The core members in our team come from Qualcomm, Cirrus Logc Broadcom, Cisco, Nokia, GE, Tencent, Chunyu doctor, traditional medical companys and famous universities at home and abroad. We have absorbed talents with different ages, 20s, 30s, and 40s years old, who are both experienced and innovative. Lohas Tech gather people with different background to challenge the hot problem, digital health.

WHERE THE WORLD
CONNECTS FOR HEALTH